Check 35,000+ stocks against 26 valuation models and 37 quality factors

Q & M DENTAL GROUP (S) LIMITED (QC7) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of Q & M DENTAL GROUP (S) LIMITED S$0.22, price S$0.49, upside -54.6%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? Yes
Add to watchlist

Healthcare · SG · ISIN SG2E73981531

QM Thin data Sep 27, 2026

Q & M DENTAL GROUP (S) LIMITED

QC7 · SG

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value 0.2200 SGD · Strongly overvalued (−54.6%)

✓Quality 60/100

!Mixed Growth (revenue 5y +7.5 %/yr)

!Thin margins · 4.7% net margin (TTM)

✓Moderate debt · generates free cash flow

✓1.6% dividend yield · Sustainable

!Trails peers (5/15)

!Narrow moat 43/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear 0.1600 SGD to bull 0.2700 SGD Growth analysisrevenue history, year by year Quality 60/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Q & M DENTAL GROUP (S) LIMITED for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range 0.1988 SGD – 0.6350 SGD · fair‑value band 0.1600 SGD – 0.2700 SGD · the 0.4850 SGD price screens above the 0.2200 SGD fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Q & M DENTAL GROUP (S) in your weekly email

Every Wednesday you see whether Q & M DENTAL GROUP (S) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China.

Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China. It offers various aesthetic/cosmetic, pediatric, CAD CAM digital, children, clear aligner, and implant dentistry services; consultation, gum disease and surgery, intraoral 3D scanning, oral surgery, root canal treatment, scaling and polishing, teeth grinding and whitening, tooth-coloured filling, and wisdom tooth surgery services; and crowns and bridges, dental X-rays and AI scan, dentures, extractions, mouth and night guards, orthodontics, and sensitive teeth. The company also provides general health services, including adult and children consultation, chronic disease management, men's health, and skin care services; cervical PAP smear, family planning, general and pre-marital health screening, smoking cessation, and weight loss management services; and cervical cancer, chicken pox, childhood, hepatitis profiling, tetanus, typhoid, influenza, and travel advice and vaccinations. In addition, it offers pre-education/extracurricular activity certifications, and pre-employment checks; and ear syringing, draining of abscess, foreign materials and warts removal, suturing, and wound care and dressing services. Further, the company provides laboratory testing services; and Covid-19 test kits, as well as higher education programmes to dentists. Additionally, it trades in dental surgery materials and equipment; develops dental healthcare software and equipment; and operates dental and medical outlets, and a dental college. The company was founded in 1996 and is headquartered in Singapore. Q & M Dental Group (Singapore) Limited operates as a subsidiary of Quan Min Holdings Pte. Ltd.

Stock analysis

Q & M DENTAL GROUP (S) LIMITED (QC7) currently trades at 0.4850 SGD, while our model-based Fair Value estimate is 0.2200 SGD, 54.6% below the price, so the stock looks overvalued today.

Valuation

Bull case: the Growth DCF group reads highest at a median of 0.3600 SGD per share, and 3 of the 25 models we run sit above the 0.4850 SGD price.

Bear case: the Asset-Based group reads lowest at 0.0700 SGD, and 22 of the 25 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.1600 SGD (bear) to 0.2700 SGD (bull), the price of 0.4850 SGD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Q & M DENTAL GROUP (S) LIMITED reported revenue of 197M SGD in FY2025 versus 205M SGD in FY2021, a compound −1.0%/yr. Reported net income was 9.3M SGD in FY2025, compounding −25.6%/yr from FY2021.

Key figures

Market cap 521M SGD (≈ $407M) · P/E ratio 48.5 · P/S ratio 2.29 · EPS (TTM) 0.0100 SGD · Dividend yield 1.6% · Net margin 4.7% · Return on equity 8.1% · Return on assets (EBIT) 11.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 24% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −55%, QC7 screens richer than that median.

Fair Value models

Bear 0.1600 SGD Fair Value 0.2200 SGD Bull 0.2700 SGD

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0015 SGD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF 0.3300 SGD 0.4600 SGD 0.6300 SGD 81

Growth DCF 0.3400 SGD 0.4500 SGD 0.6000 SGD 79

Owner Earnings 0.2600 SGD 0.3600 SGD 0.4900 SGD 77

All 25 models by family

DCF Models

FCF DCF 0.3300 SGD 0.4600 SGD 0.6300 SGD 81

Owner Earnings 0.2600 SGD 0.3600 SGD 0.4900 SGD 77

5Y Revenue Exit 0.2400 SGD 0.3500 SGD 0.4800 SGD 73

5Y EBITDA Exit 0.3600 SGD 0.5700 SGD 0.8000 SGD 75

5Y P/E Exit 0.2000 SGD 0.2800 SGD 0.3600 SGD 72

10Y Revenue Exit 0.2700 SGD 0.3700 SGD 0.4900 SGD 67

10Y EBITDA Exit 0.3400 SGD 0.5100 SGD 0.7100 SGD 68

10Y P/E Exit 0.2500 SGD 0.3300 SGD 0.4100 SGD 65

Earnings-Based

Graham-Dodd 0.0700 SGD 0.1700 SGD 0.2200 SGD 65

PEG = 1.0 0.0300 SGD 0.0400 SGD 0.0600 SGD 56

EPV 0.1400 SGD 0.1700 SGD 0.1900 SGD 74

Dividend Discount

Gordon GGM 0.0900 SGD 0.1400 SGD 0.2100 SGD 67

DDM Multi-Stage 0.0900 SGD 0.1200 SGD 0.1600 SGD 67

Multiples

P/E Multiple 0.1600 SGD 0.2200 SGD 0.2700 SGD 63

P/S Multiple 0.1300 SGD 0.1700 SGD 0.2100 SGD 58

P/B Multiple 0.1300 SGD 0.1700 SGD 0.2100 SGD 55

EV/EBIT 0.2800 SGD 0.3800 SGD 0.4800 SGD 66

EV/EBITDA 0.4400 SGD 0.6000 SGD 0.7600 SGD 67

EV/Revenue 0.1900 SGD 0.2900 SGD 0.3800 SGD 53

Asset-Based

NCAV (Graham) 0.0600 SGD 0.0700 SGD 0.1100 SGD 54

Growth DCF

Growth DCF 0.3400 SGD 0.4500 SGD 0.6000 SGD 79

Rev-Margin DCF 0.2400 SGD 0.3600 SGD 0.4800 SGD 73

Economic Profit

Residual Income 0.0900 SGD 0.1000 SGD 0.1100 SGD 76

ROIC Compounder 0.1500 SGD 0.1800 SGD 0.2200 SGD 72

Growth Earnings

Growth-Adj P/E 0.1200 SGD 0.1800 SGD 0.2300 SGD 67

Open the full fair value analysis →

Notify me when QC7 reaches fair value

Put QC7 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 60/100

Of which business quality 60 · Market factors (momentum, volatility) 46

Profitability 45

Margins and returns on capital today

Quality Growth 20

Are margins and returns improving?

Cashflow 81

Earnings quality: real cash, not paper profit

Fin. Strength 57

Balance sheet, leverage, solvency risk

Investment 79

Disciplined investing over empire-building

Low Volatility 74

Calm price path (market factor)

Momentum 35

Price trend over the last 3–12 months (market factor)

52W Momentum 33

Distance to the 52-week high (market factor)

Net Issuance 82

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 75/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+9.2%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+2.9%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+7.5%

Start year 2020 (pandemic). Over 10 years: +4.8% a year

Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+8.9%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

−15.4%

Earnings growth per share plus dividend.

Earnings per share, growth per year−17.0%

Dividend (yield on the price)1.6%

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.19% → 12%

Growth Forecast

A lot of optimism in the price

The price assumes about as much growth as the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+8.8%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+5.1%

Yearly sales growth analysts expect, extended to five years.

After inflation (Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about +6.6% a year for the price and +3.0% for the forecasts.

Forecast 2026 (sales)+7.4%

Forecast 2027 (sales)+5.1%

Projected 2028 (sales)+4.7%

Projected 2029 (sales)+4.3%

Projected 2030 (sales)+3.9%

QC7 screens overvalued: fair value 55% below the price. Compare with HCA Healthcare, Inc →

Compare Q & M DENTAL GROUP (S) LIMITED with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 244 stocks

Beats the industry median on 5/15 measures

Overall it trails its industry peers.

Valuation

Quality Score 60 · Above median

Fair Value upside −54.6% · Bottom 25%

Profitability

Return on equity (TTM) 8.1% · Above median

Return on assets 4.7% · Above median

Net margin (TTM) 4.7% · Below median

Operating margin (TTM) 10.1% · Above median

Growth and dividend

Revenue growth 18.5% · Top 25%

Dividend yield (TTM) 1.6% · Below median

Balance sheet

Debt / equity 1.37× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (TTM) 48.5× · Priciest 25%

P/B 4.99× · Priciest 25%

P/S (TTM) 2.64× · Priciest 25%

P/FCF 16.3× · Pricier than median

EV/EBITDA 19.5× · Priciest 25%

PEG 1.97× · Pricier than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 33

FUTURE (revenue growth)93 · sector 29

PAST (return on equity)33 · sector 31

HEALTH (low debt)32 · sector 89

DIVIDEND (yield)33 · sector 38

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
HCA Healthcare, Inc HCA	$431.63	$597.97	+39%
Fresenius SE FRE	€46.15	€34.49	−25%
Dr. Sulaiman Al Habib Medical Services Group 4013	225.00 SAR	109.45 SAR	−51%
Tenet Healthcare Corporation THC	$257.93	$274.35	+6%
IHH Healthcare Berhad, an investment holding company, 5225	8.03 MYR	4.87 MYR	−39%
Apollo Hospitals Enterprise Limited APOLLOHOSP	₹8,889	₹2,908	−67%
Encompass Health Corporation EHC	$123.47	$94.47	−23%
Fresenius Medical Care AG FMS	$22.27	$45.84	+106%
DaVita Inc DVA	$178.07	$215.81	+21%
Aier Eye Hospital Group 300015	¥7.91	¥10.86	+37%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Q & M DENTAL GROUP (S) LIMITED · Fair Value
0.2200 SGD −55%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/QC7" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Q &amp; M DENTAL GROUP (S) LIMITED · Fair Value</span><br><b style="font-size:20px">0.2200 SGD</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−55%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Q & M DENTAL GROUP (S) LIMITED Fair Value". https://www.fairvalue-calculator.com/stock/QC7

Frequently asked questions

Is Q & M DENTAL GROUP (S) LIMITED (QC7) overvalued or undervalued?

As of Sep 27, 2026, our model estimates a fair value of 0.2200 SGD versus a price of 0.4850 SGD, about −55% upside (overvalued).

What is the fair value of QC7?

Our model-based fair value for Q & M DENTAL GROUP (S) LIMITED is 0.2200 SGD (as of Sep 27, 2026), built from audited fundamentals. The current price: 0.4850 SGD.

What is the quality score of QC7?

Q & M DENTAL GROUP (S) LIMITED has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Q & M DENTAL GROUP (S) LIMITED (QC7)?

Our model-based price target is the fair value of 0.2200 SGD (as of Sep 27, 2026) from 25 valuation models. Cautious scenario 0.1600 SGD, optimistic scenario 0.2700 SGD. It is a calculation from audited fundamentals, not an analyst target.

What is the Q & M DENTAL GROUP (S) LIMITED stock forecast for 2026?

Our models put fair value at 0.2200 SGD, about −55% upside versus a price of 0.4850 SGD (overvalued). Cautious scenario 0.1600 SGD, optimistic scenario 0.2700 SGD. The calculation is refreshed regularly with new filings.

What is the revenue of Q & M DENTAL GROUP (S) LIMITED (QC7)?

Q & M DENTAL GROUP (S) LIMITED reported trailing-twelve-month revenue of about 197M SGD (latest available figure, as of Sep 27, 2026).

Does Q & M DENTAL GROUP (S) LIMITED pay a dividend?

Q & M DENTAL GROUP (S) LIMITED currently shows a dividend yield of about 1.65% relative to its recent price (as of Sep 27, 2026).

What growth is priced into Q & M DENTAL GROUP (S) LIMITED (QC7)?

For today's price to be fair in a discounted-cash-flow model, Q & M DENTAL GROUP (S) LIMITED would have to grow free cash flow by +8.8 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.5 % per year. As of Sep 27, 2026.

What discount rate (WACC) does the fair value of QC7 use?

Our models discount Q & M DENTAL GROUP (S) LIMITED at 10.5 %: a base by market capitalisation (small), damped by beta 0.81, country premium for Singapore. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Q & M DENTAL GROUP (S) LIMITED that is +8.8 % per year a year over ten years, using the same discount rate (10.5 %) and the same formula as our fair value.

How much growth has Q & M DENTAL GROUP (S) LIMITED (QC7) delivered so far?

Over the past 5 years revenue at Q & M DENTAL GROUP (S) LIMITED grew +7.5 % a year. The price currently implies +8.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Q & M DENTAL GROUP (S) LIMITED (QC7) growing?

The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Q & M DENTAL GROUP (S) LIMITED (+8.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The free-cash-flow yield on the price is 6.96 %: that much free cash flow Q & M DENTAL GROUP (S) LIMITED produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Q & M DENTAL GROUP (S) LIMITED (QC7)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Q & M DENTAL GROUP (S) LIMITED it is 0.2200 SGD per share (as of Sep 27, 2026), against a price of 0.4850 SGD. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).

Is Q & M DENTAL GROUP (S) LIMITED stock overvalued or undervalued in 2026?

As of Sep 27, 2026, QC7 trades above its calculated fair value: price 0.4850 SGD, fair value 0.2200 SGD, a gap of about −55% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of QC7?

No. The price is what the market pays today (0.4850 SGD); the fair value is what the company's own numbers justify (0.2200 SGD). For Q & M DENTAL GROUP (S) LIMITED the two are 0.2650 SGD per share apart. That gap is exactly why we show both numbers side by side.

How much is Q & M DENTAL GROUP (S) LIMITED worth?

The market values Q & M DENTAL GROUP (S) LIMITED at about 521M SGD (market capitalisation, as of Sep 27, 2026). Per share that is 0.4850 SGD; our models calculate a fair value of 0.2200 SGD per share.

What do the bullish and bearish scenarios say about QC7?

Our models span a range for Q & M DENTAL GROUP (S) LIMITED: cautious scenario 0.1600 SGD, base 0.2200 SGD, optimistic 0.2700 SGD per share (as of Sep 27, 2026, price 0.4850 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of QC7?

Q & M DENTAL GROUP (S) LIMITED trades at a price-to-earnings ratio of 48.5 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.2200 SGD is built from several models across several years. Other multiples: PEG 2.0, P/B 5.0, P/S 2.6, EV/EBITDA 19.5.

What is the PEG ratio of QC7?

The PEG ratio of Q & M DENTAL GROUP (S) LIMITED is 1.97 (P/E divided by earnings growth, as of Sep 27, 2026). That is above 1, so the growth is already paid for in the price.

How solid is the balance sheet of Q & M DENTAL GROUP (S) LIMITED (QC7)?

Balance-sheet figures for Q & M DENTAL GROUP (S) LIMITED (as of Sep 27, 2026): return on equity 8.1%, debt of 1.37 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.

How far is QC7 from its 52-week high?

Q & M DENTAL GROUP (S) LIMITED trades at 0.4850 SGD, about 24% below its 52-week high of 0.6350 SGD and 11% above the low of 0.4364 SGD (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of 0.2200 SGD is for.

Which stocks are comparable to Q & M DENTAL GROUP (S) LIMITED?

From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Q & M DENTAL GROUP (S) LIMITED stock attractive at the current price?

The data as of Sep 27, 2026: price 0.4850 SGD, calculated fair value 0.2200 SGD (−55%), Quality Score 60/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of QC7 calculated?

We run Q & M DENTAL GROUP (S) LIMITED through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.2200 SGD, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.5 % above its aggregate fair value. Q & M DENTAL GROUP (S) LIMITED itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The closing price on Oct 1, 2026 was 0.4850 SGD. Our model-based fair value is 0.2200 SGD, about −55% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Q & M DENTAL GROUP (S) LIMITED right now?

The price sits above even our optimistic bull case (0.2700 SGD). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Q & M DENTAL GROUP (S) LIMITED

How large is the market capitalisation of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The market capitalisation of Q & M DENTAL GROUP (S) LIMITED is 521M SGD (≈ $407M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The price-to-sales ratio of Q & M DENTAL GROUP (S) LIMITED is 2.29 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Q & M DENTAL GROUP (S) LIMITED (QC7)?

Earnings per share at Q & M DENTAL GROUP (S) LIMITED are 0.0100 SGD (price ÷ EPS = P/E 48.5). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The dividend yield of Q & M DENTAL GROUP (S) LIMITED is 1.6% (payout 80.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The net margin of Q & M DENTAL GROUP (S) LIMITED is 4.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The return on equity (ROE) of Q & M DENTAL GROUP (S) LIMITED is 8.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Q & M DENTAL GROUP (S) LIMITED (QC7)?

On an EBIT basis the return on assets of Q & M DENTAL GROUP (S) LIMITED is 11.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Q & M DENTAL GROUP (S) LIMITED (QC7)?

The operating margin of Q & M DENTAL GROUP (S) LIMITED is 10.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Q & M DENTAL GROUP (S) LIMITED (QC7)?

Revenue at Q & M DENTAL GROUP (S) LIMITED is growing +18.5% versus a year earlier (3y avg +2.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Q & M DENTAL GROUP (S) LIMITED (QC7)?

Earnings per share at Q & M DENTAL GROUP (S) LIMITED are growing +18.1% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Q & M DENTAL GROUP (S) LIMITED (QC7) carry?

The net debt of Q & M DENTAL GROUP (S) LIMITED is 26.3M SGD (fiscal year 2025, ≈ 0.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Q & M DENTAL GROUP (S) LIMITED in the live analysis

One click puts Q & M DENTAL GROUP (S) LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.